rs143830019

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B.

Score: -20 - Benign
-20
-12 -7 -6 -1 0 5 6 9 10 12
BP4_StrongBP6_Very_StrongBS1BS2

The NM_001277115.2(DNAH11):​c.3634T>C​(p.Tyr1212His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000667 in 1,579,026 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y1212C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00065 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00067 ( 3 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.08

Publications

3 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003771484).
BP6
Variant 7-21601604-T-C is Benign according to our data. Variant chr7-21601604-T-C is described in ClinVar as [Benign]. Clinvar id is 257883.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00065 (99/152328) while in subpopulation EAS AF = 0.0116 (60/5184). AF 95% confidence interval is 0.00923. There are 0 homozygotes in GnomAd4. There are 55 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.3634T>C p.Tyr1212His missense_variant Exon 18 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.3634T>C p.Tyr1212His missense_variant Exon 18 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.000650
AC:
99
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0115
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00292
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00126
AC:
286
AN:
227500
AF XY:
0.00117
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0105
Gnomad FIN exome
AF:
0.00375
Gnomad NFE exome
AF:
0.000229
Gnomad OTH exome
AF:
0.000368
GnomAD4 exome
AF:
0.000669
AC:
954
AN:
1426698
Hom.:
3
Cov.:
32
AF XY:
0.000641
AC XY:
451
AN XY:
703978
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32408
American (AMR)
AF:
0.00
AC:
0
AN:
40684
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25104
East Asian (EAS)
AF:
0.0170
AC:
663
AN:
39006
South Asian (SAS)
AF:
0.000134
AC:
11
AN:
81852
European-Finnish (FIN)
AF:
0.00349
AC:
184
AN:
52722
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5636
European-Non Finnish (NFE)
AF:
0.0000614
AC:
67
AN:
1090524
Other (OTH)
AF:
0.000476
AC:
28
AN:
58762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152328
Hom.:
0
Cov.:
32
AF XY:
0.000738
AC XY:
55
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41576
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0116
AC:
60
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00292
AC:
31
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000514
Hom.:
1
Bravo
AF:
0.000536
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.00103
AC:
124
Asia WGS
AF:
0.00549
AC:
19
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Jan 21, 2025
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
18
DANN
Benign
0.93
DEOGEN2
Benign
0.022
.;.;T
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.75
T;T;T
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
.;.;L
PhyloP100
2.1
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.27
.;N;.
REVEL
Benign
0.086
Sift
Benign
0.63
.;T;.
Polyphen
1.0
.;.;D
Vest4
0.33
MVP
0.32
ClinPred
0.053
T
GERP RS
4.5
Varity_R
0.090
gMVP
0.40
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143830019; hg19: chr7-21641222; API